FDA Approves First Muscle-Targeted Therapy for SMA

Medical Educational Resource

We're accelerating the delivery of treatments and cures.

MDA Case Discussions: Navigating Myasthenia Gravis Diagnosis & Treatment Decisions

Activity Snapshot

Activity Type: 
On-Demand Webinar
Release Date: 
Tuesday, October 6, 2026
Expiration Date: 
Friday, October 6, 2028
Sponsor Information: 

This program is supported in part by independent medical education grants to MDA from argenx, Catalyst Pharmaceuticals, Johnson & Johnson, and UCB, Inc.

Faculty

Michael Slama, MD, PhD
Neuromuscular Neurologist, Director, Myasthenia Gravis Clinic

Mass General Brigham Hospital

Lindsay Tetreault, MD
Neuromuscular Neurologist

Mass General Brigham Hospital

Activity Overview: 

This program invites learners to dive into three cases that illustrate the complexity of MG diagnosis and decision-making. Learners will leave the session with improved awareness of available diagnostic tools, therapies, and questions to ask to guide care decisions.

Learning Objectives: 

Apply diagnostic reasoning and testing strategies to MG cases with overlapping/atypical symptoms. 
Evaluate treatment options and tailor management decisions across diverse MG presentations. 
Incorporate patient goals into individualized MG treatment planning. 

How to Obtain CME credits : 

Access CE dashboard here.

Login or Create an account in the system. (All 1st time users are required to create an account)

Proceed to “Register/Take Course” Tab to complete the Course Evaluation & Certificate steps for the activity.

If you have questions about this CE activity, please contact AKH Inc at bethany@akhcme.com.

Faculty Disclosures: